MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT.
Siemaszko J, Dratwa M, Szeremet A, Majcherek M, Czyż A, Sobczyk-Kruszelnicka M, Fidyk W, Solarska I, Nasiłowska-Adamska B, Skowrońska P, Bieniaszewska M, Tomaszewska A, Basak GW, Giebel S, Wróbel T, Bogunia-Kubik K.
Siemaszko J, et al. Among authors: tomaszewska a.
Arch Immunol Ther Exp (Warsz). 2024 Jun 7;72(1). doi: 10.2478/aite-2024-0012. eCollection 2024 Jan 1.
Arch Immunol Ther Exp (Warsz). 2024.
PMID: 38847554
Free article.